Hypertension, the silent killer, takes 10 million lives every year. It creeps forward without symptoms, often only revealing itself when it’s too late. Globally, 1 in 3 adults lives with high blood pressure, yet fewer than 20% have it under control.
In low- and middle-income countries, the stakes are even higher:
- Fragile health systems mean screening is rare.
- Millions of families are pushed into poverty by preventable strokes and heart attacks.
- Proven solutions exist, but they’re fragmented, inaccessible, and designed for those who already have reliable healthcare.
The real challenge isn’t knowing what to do, it’s finding, engaging, and keeping patients in care, especially in underserved communities.
Our Mission
At Aarogyatech, we’re building the world’s first AI-powered, low-friction hypertension detection, engagement, and control platform designed for the 3 billion people who need it most.
Our solution brings together simple, portable blood pressure monitoring and a smartphone app, or even basic SMS for those without smartphones, delivering:
- Instant diagnosis and personalized treatment plans
- Behavioral nudges in local languages
- Direct connections to affordable care providers
- Continuous follow-up to keep blood pressure under control
The Breakthrough
Most hypertension programs fail after first contact. People get screened, maybe start treatment, but drift away without support.
Aarogyatech’s “community-to-clinic loop” fixes that:
- Screen anywhere – Community health workers, using our portable BP device, can screen 100+ people a day.
- AI-driven engagement – Personalized reminders, motivational coaching, and gamification keep patients involved.
- Affordable treatment pathways – Direct access to low-cost medication, telehealth consults, and insurance partners.
Projected pilot results in Nepal (15,000 people):
We expect hypertension control rates to rise from 14% to 52% within six months, more than double the global average.
Impact at Scale
By 2030, Aarogyatech will:
- Screen 100 million people
- Control hypertension in 20 million lives
- Prevent over 5 million strokes and heart attacks
- Save health systems $20+ billion in preventable care costs
Why Now
Hypertension is the most cost-effective non-communicable disease to address:
- Every $1 invested returns $18 in productivity and healthcare savings.
- Mobile phone penetration is at record highs, even in rural areas.
- Governments are prioritizing non-communicable diseases in national health strategies.
The window of opportunity is open, but it won’t stay open forever.
The Ask
We’re actively seeking $10 million in blended capital with meaningful partners to:
- Scale across India and East Africa
- Advance AI-driven predictive tools
- Integrate with national health systems
This isn’t charity, it’s a scalable, sustainable business with proven revenue streams from:
- Service contracts
- Affordable subscriptions
- Public health data partnerships
Join Us
Invest in Aarogyatech.
Save lives. Reduce costs. End the world’s most preventable health crisis.
Because no one should die from a disease we already know how to beat.